Search clinical trials for: US-licensed Trastuzumab (Herceptin®)
Total 603 results
-
Shanghai Henlius BiotechCompleted
-
Alteogen, Inc.Cristália Produtos Químicos Farmacêuticos Ltda.Completed
-
Samsung Bioepis Co., Ltd.Completed
-
PfizerCompleted
-
Prestige Biopharma LimitedCompleted
-
Samsung Bioepis Co., Ltd.CompletedHER2 Positive Early or Locally Advanced Breast CancerCzechia
-
Bio-Thera SolutionsCompletedRheumatoid ArthritisChina
-
Bio-Thera SolutionsCompleted
-
EirGenix, Inc.Completed
-
Mylan Pharmaceuticals IncMylan GmbHCompleted
-
Bristol-Myers SquibbCompletedBreast CancerAustralia, Hungary, Canada, United Kingdom, Belgium
-
Fresenius Kabi SwissBioSim GmbHCompleted
-
University of Michigan Rogel Cancer CenterTerminatedBreast CancerUnited States
-
Boehringer IngelheimCompletedArthritis, RheumatoidSpain, United States, Korea, Republic of, Malaysia, Poland, Thailand, Bulgaria, Chile, Estonia, Germany, Hungary, New Zealand, Russian Federation, Serbia, Ukraine
-
PfizerCompleted
-
Bio-Thera SolutionsCompleted
-
MedSIRTerminatedAdvanced Breast CancerSpain
-
Prestige Biopharma LimitedRecruitingHealthy VolunteersSpain
-
Samsung Bioepis Co., Ltd.TerminatedBreast NeoplasmsUkraine, Romania, Russian Federation, France, Bulgaria, Czechia, Poland
-
PfizerCompletedCarcinoma, Metastatic BreastUnited States
-
Armando Santoro, MDTerminated
-
mAbxience Research S.L.CompletedHealthy VolunteersPoland
-
Dana-Farber Cancer InstituteGenentech, Inc.; ExelixisCompletedBreast Cancer | Brain Tumor - MetastaticUnited States
-
M.D. Anderson Cancer CenterCompleted
-
SeqirusCompleted
-
Gan and Lee Pharmaceuticals, USACompletedDiabetes MellitusGermany
-
Bio-Thera SolutionsCompleted
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Early-stage Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
Fudan UniversityHoffmann-La RocheUnknown
-
M.D. Anderson Cancer CenterCompletedDuctal Carcinoma In SituUnited States
-
Hoffmann-La RocheTerminatedUrinary Tract CancerGermany
-
Hoffmann-La RocheTerminated
-
Nantes University HospitalTerminatedRelapsed/Refractory LeukemiaFrance
-
Hoffmann-La RocheCompletedHealthy VolunteerNew Zealand
-
Hoffmann-La RocheCompletedBreast CancerItaly, Austria, Belgium, Germany, Spain, United Kingdom, Hungary, Poland, Sweden
-
Hoffmann-La RocheTerminated
-
Regione LombardiaMario Negri Institute for Pharmacological Research; Istituto Clinico HumanitasUnknownMetastatic or Locally Advanced Breast CancerItaly
-
Jonsson Comprehensive Cancer CenterCompletedBreast CancerUnited States
-
Hoffmann-La RocheGenentech, Inc.CompletedBreast CancerItaly, Spain, Sweden, China, Hong Kong, Canada, South Africa, Ukraine, United States, United Kingdom, Russian Federation, Taiwan, Australia, Mexico, Turkey, Israel, Poland, Bulgaria, Germany, France, Netherlands, Norway, India, Hungary, Brazi... and more
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedMetastatic Breast Cancer | Metastatic Gastric CancerChina
-
Xuzhou Medical UniversityUnknown
-
CelltrionCompletedHealthy SubjectsNew Zealand
-
Hoffmann-La RocheCompleted
-
Orano Med LLCCompletedStomach Neoplasms | Breast Neoplasms | Pancreatic Neoplasms | Ovarian Neoplasms | Peritoneal NeoplasmsUnited States
-
BiogenCompleted
-
National University Hospital, SingaporeNational University of SingaporeUnknownBreast Cancer | Gastric CancerSingapore
-
Spanish Breast Cancer Research GroupCompleted
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingBreast Ductal Carcinoma In SituUnited States, Canada, Puerto Rico, Korea, Republic of
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Hoffmann-La RocheCompletedBreast CancerEstonia, Hungary, Turkey, Israel, Slovakia, Bulgaria, Lithuania, Macedonia, The Former Yugoslav Republic of